ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT05172973
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT05172973
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT05172973. Non-randomized; no masking; primary purpose treatment. Start 2023-11-22 (actual); primary completion 2029-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
- Condition
- Aortic Valve Insufficiency
- Condition
- Aortic Valve Stenosis
- Intervention (Device)
- SAPIEN X4/X4S THV
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct05172973- Content hash
6680d5bc6b9d30e1868613550fba89d1f9a6b0615c39d63d18868503d2db4c48